Xenon Pharmaceuticals (XENE) Other Non Operating Income (2013 - 2026)
Xenon Pharmaceuticals (XENE) reported Other Non Operating Income of $548000.0 for Q1 2026, up 1465.71% year-over-year from $35000.0 in Q1 2025, and up 285.14% quarter-over-quarter from -$296000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Other Non Operating Income (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 14 years of Other Non Operating Income data on file, last reported at $548000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $548000.0, up 1465.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (up 255.6% YoY), and the FY2025 annual result was $1.3 million, up 226.69% from the prior year.
- Other Non Operating Income improved to $548000.0 in Q1 2026 per XENE's latest filing, from -$296000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.7 million in Q2 2025 and troughed at -$2.4 million in Q3 2022.
- A 5-year average of -$50588.2 and a median of $35000.0 in 2025 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income sank 1760.16% in 2022, then jumped 16880.0% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at $602000.0 in 2022, then tumbled by 114.95% to -$90000.0 in 2023, then slumped by 1542.22% to -$1.5 million in 2024, then surged by 79.97% to -$296000.0 in 2025, then surged by 285.14% to $548000.0 in 2026.
- Business Quant data shows XENE's Other Non Operating Income at $548000.0 in Q1 2026, -$296000.0 in Q4 2025, and -$89000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 548,000.00 |
| Dec 31, 2025 | -296,000.00 |
| Sep 30, 2025 | -89,000.00 |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 167,000.00 |
| Dec 31, 2023 | -90,000.00 |
| Sep 30, 2023 | -407,000.00 |
| Jun 30, 2023 | 383,000.00 |
| Mar 31, 2023 | 313,000.00 |
| Dec 31, 2022 | 602,000.00 |
| Sep 30, 2022 | -2.38 Mn |
| Jun 30, 2022 | -411,000.00 |
| Mar 31, 2022 | 299,000.00 |
| Dec 31, 2021 | 214,000.00 |
| Sep 30, 2021 | -128,000.00 |
| Jun 30, 2021 | 117,000.00 |